These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11462220)

  • 21. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
    Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
    J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review and update: current treatment trends for patients with retinitis pigmentosa.
    Shintani K; Shechtman DL; Gurwood AS
    Optometry; 2009 Jul; 80(7):384-401. PubMed ID: 19545852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal degeneration and local oxygen metabolism.
    Yu DY; Cringle SJ
    Exp Eye Res; 2005 Jun; 80(6):745-51. PubMed ID: 15939030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal dominant Retinitis pigmentosa: the Rho(-/-) mouse.
    Campbell M; Humphries M; Kennan A; Kenna P; Humphries P; Brankin B
    Exp Eye Res; 2006 Sep; 83(3):484-92. PubMed ID: 16643895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy progress and prospects: the eye.
    Bainbridge JW; Tan MH; Ali RR
    Gene Ther; 2006 Aug; 13(16):1191-7. PubMed ID: 16838031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa.
    O'Reilly M; Millington-Ward S; Palfi A; Chadderton N; Cronin T; McNally N; Humphries MM; Humphries P; Kenna PF; Farrar GJ
    Vision Res; 2008 Feb; 48(3):386-91. PubMed ID: 17920651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optogenetic approaches to restoring visual function in retinitis pigmentosa.
    Busskamp V; Roska B
    Curr Opin Neurobiol; 2011 Dec; 21(6):942-6. PubMed ID: 21708457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy in ocular diseases.
    Singh VK; Tripathi P
    Indian J Ophthalmol; 2002 Sep; 50(3):173-81. PubMed ID: 12355690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optogenetic therapy for retinitis pigmentosa.
    Busskamp V; Picaud S; Sahel JA; Roska B
    Gene Ther; 2012 Feb; 19(2):169-75. PubMed ID: 21993174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retinitis pigmentosa: eye sight restoration by optogenetic therapy].
    Roska B; Busskamp V; Sahel JA; Picaud S
    Biol Aujourdhui; 2013; 207(2):109-21. PubMed ID: 24103341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Animal models for retinitis pigmentosa research].
    Kohler K; Guenther E; Zrenner E
    Klin Monbl Augenheilkd; 1997 Aug; 211(2):84-93. PubMed ID: 9379644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroprotective gene therapy to treat patients with retinitis pigmentosa].
    Ikeda Y; Ishibashi T
    Fukuoka Igaku Zasshi; 2010 Sep; 101(9):183-9. PubMed ID: 21226311
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental therapeutic modalities for retinitis pigmentosa].
    Banin E; Chowers I
    Harefuah; 2004 May; 143(5):368-71, 389. PubMed ID: 15190851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.
    Tao W; Wen R; Goddard MB; Sherman SD; O'Rourke PJ; Stabila PF; Bell WJ; Dean BJ; Kauper KA; Budz VA; Tsiaras WG; Acland GM; Pearce-Kelling S; Laties AM; Aguirre GD
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3292-8. PubMed ID: 12356837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene mutations in retinitis pigmentosa and their clinical implications.
    Wang DY; Chan WM; Tam PO; Baum L; Lam DS; Chong KK; Fan BJ; Pang CP
    Clin Chim Acta; 2005 Jan; 351(1-2):5-16. PubMed ID: 15563868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iris pigment epithelial cell transplantation for degenerative retinal diseases.
    Abe T; Yoshida M; Yoshioka Y; Wakusawa R; Tokita-Ishikawa Y; Seto H; Tamai M; Nishida K
    Prog Retin Eye Res; 2007 May; 26(3):302-21. PubMed ID: 17324604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP.
    Pawlyk BS; Smith AJ; Buch PK; Adamian M; Hong DH; Sandberg MA; Ali RR; Li T
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3039-45. PubMed ID: 16123399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenoviral-mediated gene transfer to retinal explants during development and degeneration.
    Pang J; Cheng M; Stevenson D; Trousdale MD; Dorey CK; Blanks JC
    Exp Eye Res; 2004 Aug; 79(2):189-201. PubMed ID: 15325566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Range of retinal diseases potentially treatable by AAV-vectored gene therapy.
    Hauswirth WW; Li Q; Raisler B; Timmers AM; Berns KI; Flannery JG; LaVail MM; Lewin AS
    Novartis Found Symp; 2004; 255():179-88; discussion 188-94. PubMed ID: 14750604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.